Search
for
Sort by
Research 241–270 of 1000+
- Toxicity of the pharmaceuticals finasteride and melengestrol acetate to benthic invertebrates
- Causes of hair loss and the developments in hair rejuvenation
- Managing polycystic ovary syndrome in primary care
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- The treatment of polycystic ovary syndrome and systematization of knowledge - literature review
- Skin manifestations of hyperandrogenism: an update
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Hormonal therapies for acne
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Chemical pharmacotherapy options for managing adult acne
- Transgender and Migraine
- Debatable Topics in PCOS Patients
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Skin diseases associated with Agent Orange and other organochlorine exposures.
- Dermatología en la Práctica Médica General Vol. 13
- Androgen Receptor Ligands: Agonists and Antagonists
- Is dehydroepiandrosterone a hormone?
- Treatment of Hair Loss
- Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
- Endocrinology of Transgender Medicine
- Aging of hair
- Polycystic Ovary Syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women